📰 Beckley Psytech News
Page 10 - Beckley Psytech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beckley Psytech. Real-time updates on events, politics, business and more.
October 4, 2021
/PRNewswire/ -- PSYCH, the premium business-to-business media and content platform for the psychedelic science and healthcare industry, today announced the...
September 15, 2021
Phase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA - News - PharmaTimes
August 17, 2021
Investegate announcements from Clarify Pharma PLC, Clarify Pharma Makes First Capital Investment
August 17, 2021
TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green | Financial News
August 16, 2021
An Oxford based company which uses psychedelic medicines to treat neurological disorders has completed an oversubscribed £58m funding round.
August 16, 2021
Beckley Psytech's Lady Amanda Feilding has gained notoriety for her research into trepanning, which involves drilling holes into the skull
June 11, 2021
5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. ...
May 30, 2021
DMT is the psychoactive agent found in Ayahuasca, a drink that has been prepared by Amazonian rainforest communities for thousands of years.
May 25, 2021
Share: Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies VANCOUVER, BC, May 25, 2021 /CNW/ - Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe, is pleased to announce the chairs of its Clinical and Scientific Advisory Boards. The company welcomes Pro...
May 13, 2021
Longread: Psilocybin-assisted Therapy for Mental Health: A New Paradigm? Pioneering psychedelic research We are living through a mental health crisis. Existing treatments barely scratch the surface of the problem, and have not translated into real world benefit for a huge number of people. An estimated 1 billion people worldwide now live with a mental disorder, with depression affecting an estimated 264 million people of all ages around the world. It is the single biggest contributing facto...